Informations:
Erreur:
ID
14359
Description
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII); ODM derived from: https://clinicaltrials.gov/show/NCT00455923
Lien
https://clinicaltrials.gov/show/NCT00455923
Mots-clés
Versions (1)
- 12/04/2016 12/04/2016 -
Détendeur de droits
CC BY-NC 3.0
Téléchargé le
12 avril 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Asthma NCT00455923
Eligibility Asthma NCT00455923
- StudyEvent: Eligibility
Similar models
Eligibility Asthma NCT00455923
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
informed consent
Item
willing to give informed consent.
boolean
C0021430 (UMLS CUI [1])
age
Item
males or females aged 18-70.
boolean
C0001779 (UMLS CUI [1])
able to understand and complete dairy cards
Item
able to understand and complete dairy cards.
boolean
C1321605 (UMLS CUI [1])
mild persistent asthma
Item
mild persistent asthma according to gina. in addition, at randomisation subjects were required to have: 1. day time symptoms more than once a week but not every day. 2. night-time symptoms not more than once a week. 3. fev1 >80% predicted 4. pc20 <8mg/ml
boolean
C1960046 (UMLS CUI [1])
C0748133 (UMLS CUI [2])
C1714620 (UMLS CUI [3])
C1276804 (UMLS CUI [4,1])
C0436350 (UMLS CUI [4,2])
C2957235 (UMLS CUI [5,1])
C0436350 (UMLS CUI [5,2])
C0748133 (UMLS CUI [2])
C1714620 (UMLS CUI [3])
C1276804 (UMLS CUI [4,1])
C0436350 (UMLS CUI [4,2])
C2957235 (UMLS CUI [5,1])
C0436350 (UMLS CUI [5,2])
asthma medication change
Item
change to regular asthma medication in 4-weeks prior to visit 1.
boolean
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0580105 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C0004096 (UMLS CUI [1,2])
C0580105 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
corticosteroids
Item
use of oral, depot or parenteral corticosteroids within 8 weeks of visit 1.
boolean
C0001617 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
lower respiratory tract infection
Item
lower respiratory tract within 4 weeks of visit 1
boolean
C0149725 (UMLS CUI [1])
investigational drug
Item
received investigational study drug within 4 weeks of visit
boolean
C0013230 (UMLS CUI [1])
smoking history
Item
smoking history of >10 pack years of more.
boolean
C1519384 (UMLS CUI [1,1])
C1277691 (UMLS CUI [1,2])
C1277691 (UMLS CUI [1,2])
serious uncontrolled disease
Item
serious uncontrolled disease.
boolean
C0009488 (UMLS CUI [1])
comorbidity limiting study protocol
Item
medical conditions or medications known to affect the assessments or endpoints.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
alcohol or drug abuse
Item
evidence of alcohol or drug abuse.
boolean
C0038586 (UMLS CUI [1])
pregnancy or planned pregnancy
Item
known pregnancy or planned pregnancy.
boolean
C0032961 (UMLS CUI [1])
C0032961 (UMLS CUI [2,1])
C1283828 (UMLS CUI [2,2])
C0032961 (UMLS CUI [2,1])
C1283828 (UMLS CUI [2,2])
hypersensitivity to inhaled corticosteroids, beta-agonists or lactose
Item
known or suspected hypersensitivity to inhaled corticosteroids, beta-agonists or lactose.
boolean
C0020517 (UMLS CUI [1,1])
C2065041 (UMLS CUI [1,2])
C0001644 (UMLS CUI [1,3])
C0022949 (UMLS CUI [1,4])
C2065041 (UMLS CUI [1,2])
C0001644 (UMLS CUI [1,3])
C0022949 (UMLS CUI [1,4])
previous enrollment in the study
Item
previous enrollment in the study
boolean
C2348568 (UMLS CUI [1])